Cardio3 BioSciences Raises $24.9 Million Through a Private Placement
5/8/2013 6:29:26 AM
More...
|
Results From Cardio3 BioSciences C-CURE™ Trial Published in the Journal of the American College of Cardiology
4/11/2013 9:50:12 AM
More...
|
Cardio3 BioSciences Appoints Dr. Alexander Milstein as Vice President of Clinical Development
8/21/2012 12:02:35 PM
More...
|
Cardio3 BioSciences Has Been Selected to Present C3BS-CQR-1 Trial Data in Late Breaking Clinical Trial Session at European Society of Cardiology 2012 Heart Failure Congress
5/21/2012 9:53:09 AM
More...
|
Cardio3 BioSciences Announces CE Marking for its C-Cath® Injection Catheter
5/9/2012 6:39:36 AM
More...
|
Cardio3 BioSciences Granted GMP Certification
4/12/2012 9:57:26 AM
More...
|
Cardio3 BioSciences ReceivesISO-13485 Certification
2/29/2012 10:46:56 AM
More...
|
Cardio3 BioSciences Secures Additional €3.1 Million in Non-dilutive Funding From the Walloon Region and the European Commission
1/10/2012 10:01:45 AM
More...
|
Cardio3 BioSciences Establishes US Subsidiary in Rochester, MN
9/22/2011 5:57:50 AM
More...
|
Cardio3 BioSciences Announces Significant Progress in its Program for the Treatment of Acute Myocardial Infarction
12/28/2010 8:32:58 AM
More...
|
|